SS-31 is a small, water-soluble tetrapeptide from the Szeto–Schiller family, designed to target the inner mitochondrial membrane. Research suggests it may enhance ATP production, improve mitochondrial function, and reduce oxidative stress by lowering inflammatory cytokines—supporting studies in neurodegenerative, cardiovascular, metabolic, and kidney health